U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

HEOR & HTA Manager

Biology & BiotechUpdated on Nov 14
Full-timeTokyo, JapanNo salary listedIn-person

About the Job

Requirements

  • At least three years of practical experience in health economics research, especially cost-effectiveness evaluation and drug pricing and reimbursement submissions, in the pharmaceutical industry, Ministry of Health, Labour and Welfare, or a think tank; this includes negotiations with the Ministry’s Medical Economics Division or C2H, global collaboration, vendor management, company analyses, and preparation of reimbursement submission documents.
  • Experience planning and executing health economics and outcomes research (HEOR).
  • Experience setting, designing, or developing health economic evaluation models.
  • Experience considering and selecting data for use in analyses.
  • Ability to propose health-economic evidence generation to support drug pricing and reimbursement strategies.
  • Business-level English proficiency.
  • Experience collaborating with internal and external stakeholders and managing projects.

Responsibilities

  • Develop Japan-market health technology assessment (HTA) and drug pricing strategies and engage with authorities.
  • Lead preparation of cost-effectiveness evaluation materials for products designated for HTA and handle regulatory-authority interactions.
  • Support new-drug and medium- to long-term drug pricing and reimbursement strategies, and localize health economic models developed by UCB headquarters in Belgium for the Japanese market.
  • Lead generation of evidence demonstrating health-economic value from clinical development through post-launch.
  • Provide HEOR input on trial design and endpoint selection for Phase II through Phase III/IV clinical trials.
  • Research and understand developments in drug pricing and HTA policy reforms through domestic industry activities.
  • Lead preparation for Japan HTA in line with global product commercialization strategies, and plan and execute HEOR projects.
  • Conduct systematic reviews, meta-analyses, and indirect comparison analyses for cost-effectiveness analyses, identify evidence gaps, and, as needed, plan and conduct studies and analyze health economic and clinical outcome data.
  • Disseminate evidence and support the research environment through HEOR-related conference presentations and publications.
  • Coordinate with development, market access, global teams, external vendors, and key opinion leaders to advance HEOR projects and manage their progress.
  • Monitor implementation of Japan’s HTA system and participate in considering policy recommendations through the access committee of the EFPIA Market Access Partnership.

Desired Qualifications

  • Experience with drug pricing and reimbursement submissions, new-product development, or new-product planning.
  • Co-authorship of health economics research papers, including cost-effectiveness studies.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs